2020 ~
- 2022
100 Billion KRW in Sales
New product launches including Teneglip Tab.
KGMP approval for Iksan Manufacturing Plant
- 2021
81 Billion KRW in Sales
Completion of construction and registration of the Iksan plant.
Certification of the anti-corruption management system (ISO-37001)
Designation as “Small to Medium Sized Enterprise Fostering Talent”
- 2020
70 Billion KRW in Sales
Presidential commendation for the National Productivity Award
New product launches including Bronaze Enteric Coated Tab.
Commencement of construction for the Iksan plant.
Certification as an “Innovative Small to Medium Sized Enterprise” by Main-Biz
2011 ~ 2019
-
2019
64 Billion KRW in Sales
New product launches including ESOPM Tab.
-
2018
43 Billion KRW in Sales
Purchase of land for the Iksan plant.
Relocation of the headquarters building to Dongjak-gu, Seoul
New product launches including R-Tis Tab.
Expansion of the office building in the Gyeongsan plant
-
2017
32 Billion KRW in Sales
Purchase of the headquarters building in Dongjak-gu, Seoul
New product launches including Laybone Tab.
Certification of Mother's Pharmaceutical New Drug Development Research Institute
-
2016
24 Billion KRW in Sales
New product launches including Zerofat Cap.
-
2015
16 Billion KRW in sales
Expansion of the Gyeongsan plant (3rd floor).
New product launches including Sto M Tab.
Certification as a “Innovative technology small to medium sized enterprise” by “Innobiz”
Certification of Mother's Pharmaceutical Corporate-affiliated Research Institute
-
2014
10.5 Billion KRW in sales
Certification as a venture enterprise
-
2013
New product launches including AdreQ-A Tab.
-
2012
New product launches including Chonti 600 Tab.
Certification of dedicated research and development department
Change of company name from Anam Pharmaceutical Co., Ltd. to Mother's Pharmaceutical Co., Ltd.
-
2011
Change in product license approval
Change in business license (CEO change to Jwa Jin Kim)
